Protecting Free Vaccines Act
A BILL
To require coverage of certain immunizations recommended by the Advisory Committee on Immunization Practices under the Medicare program, the Medicaid program, the Children’s Health Insurance Program, group health plans, and health insurance coverage.
Sec. 2 Requiring coverage of certain immunizations recommended by the Advisory Committee on Immunization Practices
“2799A–11. Coverage of certain immunizations recommended by the Advisory Committee on Immunization Practices
“(a) In general—With respect to plan years occurring during the date of the enactment of this section, or beginning on or after the date of the enactment of this section and before January 1, 2030, a group health plan and a health insurance issuer offering group or individual health insurance coverage shall provide coverage for and shall not impose any cost sharing requirements for immunizations that had in effect a recommendation from the Advisory Committee on Immunization Practices of the Centers for Disease Control and Prevention with respect to the individual involved as of October 25, 2024, including such an immunization as updated or changed after that date under a supplement to a biologics license application approved by the Food and Drug Administration.
“(b) Special rule—Subsection (a) shall not apply in the case of an immunization administered during the minimum interval established under section 2713(b) with respect to such immunization.”
“726. Coverage of certain immunizations recommended by the Advisory Committee on Immunization Practices
“(a) In general—With respect to plan years occurring during the date of the enactment of this section, or beginning on or after the date of the enactment of this section and before January 1, 2030, a group health plan and a health insurance issuer offering group health insurance coverage shall provide coverage for and shall not impose any cost sharing requirements for immunizations that had in effect a recommendation from the Advisory Committee on Immunization Practices of the Centers for Disease Control and Prevention with respect to the individual involved as of October 25, 2024, including such an immunization as updated or changed after that date under a supplement to a biologics license application approved by the Food and Drug Administration.
“(b) Special rule—Subsection (a) shall not apply in the case of an immunization administered during the minimum interval established under section 2713(b) of the Public Health Service Act with respect to such immunization.”
“9826. Coverage of certain immunizations recommended by the Advisory Committee on Immunization Practices
“(a) In general—With respect to plan years occurring during the date of the enactment of this section, or beginning on or after the date of the enactment of this section and before January 1, 2030, a group health plan shall provide coverage for and shall not impose any cost sharing requirements for immunizations that had in effect a recommendation from the Advisory Committee on Immunization Practices of the Centers for Disease Control and Prevention with respect to the individual involved as of October 25, 2024, including such an immunization as updated or changed after that date under a supplement to a biologics license application approved by the Food and Drug Administration.
“(b) Special rule—Subsection (a) shall not apply in the case of an immunization administered during the minimum interval established under section 2713(b) of the Public Health Service Act with respect to such immunization.”
“(i) recommendations”
“(ii) for plan years occurring during the date of the enactment of this clause, or beginning on or after the date of the enactment of this clause and before January 1, 2030, in the case of a vaccine with respect to which such a recommendation is revoked with respect to the individual involved on or after October 25, 2024, including such a vaccine as updated or changed after that date under a supplement to a biologics license application approved by the Food and Drug Administration, the most recent recommendation that was in effect with respect to such vaccine and such individual prior to such revocation.”
“(i) approved”
“(ii) for the period beginning on the date of the enactment of this clause and ending on December 31, 2029, approved vaccines, and the administration of such vaccines, that were recommended by such advisory committee with respect to the individual involved as of October 25, 2024, including such a vaccine as updated or changed after that date under a supplement to a biologics license application approved by the Food and Drug Administration.”
“(iii) For the period beginning on the date of the enactment of this clause and ending on December 31, 2029, the provider will not take into account any change in the schedule described in clause (i) that removes the recommendation to administer a pediatric vaccine with respect to the vaccine-eligible child involved if such pediatric vaccine was recommended with respect to such child under such schedule as of October 25, 2024, including with respect to such pediatric vaccine as updated or changed after that date under a supplement to a biologics license application approved by the Food and Drug Administration.”
“(9) Coverage of adult vaccines—Notwithstanding the previous provisions of this section, a State may not provide for medical assistance through enrollment of an individual with benchmark coverage or benchmark-equivalent coverage under this section unless such coverage includes (and does not impose any deduction, cost sharing, or similar charge for) the medical assistance described in section 1905(a)(13)(B).”
“(13) Required coverage of certain vaccines recommended by the Advisory Committee on Immunization Practices—Regardless of the type of coverage elected by a State under subsection (a), the child health assistance provided for a targeted low-income child shall include coverage, during the period beginning on the date of the enactment of this paragraph and ending on December 31, 2029, of vaccines, and the administration of such vaccines, that had in effect a recommendation from the Advisory Committee on Immunization Practices of the Centers for Disease Control and Prevention with respect to the child involved as of October 25, 2024, including such a vaccine as updated or changed after that date under a supplement to a biologics license application approved by the Food and Drug Administration.”